Loading…
Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation
Saved in:
Published in: | Pediatric blood & cancer 2024-12, p.e31489 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | e31489 |
container_title | Pediatric blood & cancer |
container_volume | |
creator | Sheikh, Irtiza N Uwaezuoke, Destiny Okeleji, Olayinka Quesada, Andres Herzog, Cynthia E Ragoonanan, Dristhi Tewari, Priti Petropoulos, Demetrios McCall, David Nunez, Cesar Roth, Michael Cuglievan, Branko Khazal, Sajad |
description | |
doi_str_mv | 10.1002/pbc.31489 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3147484896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3147484896</sourcerecordid><originalsourceid>FETCH-LOGICAL-p562-4c81bfd9db34487dab23acc113359cf490b26bcec37eb1d41c7f01d11870ce743</originalsourceid><addsrcrecordid>eNpNkMFu1TAQRS0EoqWw4AfQLFk0xY6dl2RZUl5BeohKRGL5NLYn1JDYwbFVwq_xcwQoEqu5Gh0dXV3Gngt-ITgvX83aXEihmvYBOxWVqoqKi_rhf_mEPVmWLxu641XzmJ3ItuZl05an7GcfCdNEPkEYAOGGrMMUnYEbTO73-86lW-hCJHjtvHX-M-zRpBDh0uRE8H6lMTgLB8pfaXKbISyp6NYUUvi-afpbijiv8OmPZk0YUTtP53CF2YeYtTPOnwN6C9c0pfwjT6hhH8Yx3JEFvcLHRBN0NI7QR_TLPKJPW7fgn7JHA44LPbu_Z6zfv-m7t8Xhw_W77vJQzNWuLJRphB5sa7VUqqkt6lKiMUJIWbVmUC3X5U4bMrImLawSph64sEI0NTdUK3nGXv7VzjF8y7Sk4-QWs_VBTyEvx235WjXb-rsNfXGPZj2RPc7RTRjX47-95S-XBoTq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147484896</pqid></control><display><type>article</type><title>Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Sheikh, Irtiza N ; Uwaezuoke, Destiny ; Okeleji, Olayinka ; Quesada, Andres ; Herzog, Cynthia E ; Ragoonanan, Dristhi ; Tewari, Priti ; Petropoulos, Demetrios ; McCall, David ; Nunez, Cesar ; Roth, Michael ; Cuglievan, Branko ; Khazal, Sajad</creator><creatorcontrib>Sheikh, Irtiza N ; Uwaezuoke, Destiny ; Okeleji, Olayinka ; Quesada, Andres ; Herzog, Cynthia E ; Ragoonanan, Dristhi ; Tewari, Priti ; Petropoulos, Demetrios ; McCall, David ; Nunez, Cesar ; Roth, Michael ; Cuglievan, Branko ; Khazal, Sajad</creatorcontrib><identifier>ISSN: 1545-5017</identifier><identifier>EISSN: 1545-5017</identifier><identifier>DOI: 10.1002/pbc.31489</identifier><identifier>PMID: 39702892</identifier><language>eng</language><publisher>United States</publisher><ispartof>Pediatric blood & cancer, 2024-12, p.e31489</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-6411-8353 ; 0009-0005-3770-1139 ; 0000-0003-4869-8818 ; 0000-0003-2297-9670</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39702892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheikh, Irtiza N</creatorcontrib><creatorcontrib>Uwaezuoke, Destiny</creatorcontrib><creatorcontrib>Okeleji, Olayinka</creatorcontrib><creatorcontrib>Quesada, Andres</creatorcontrib><creatorcontrib>Herzog, Cynthia E</creatorcontrib><creatorcontrib>Ragoonanan, Dristhi</creatorcontrib><creatorcontrib>Tewari, Priti</creatorcontrib><creatorcontrib>Petropoulos, Demetrios</creatorcontrib><creatorcontrib>McCall, David</creatorcontrib><creatorcontrib>Nunez, Cesar</creatorcontrib><creatorcontrib>Roth, Michael</creatorcontrib><creatorcontrib>Cuglievan, Branko</creatorcontrib><creatorcontrib>Khazal, Sajad</creatorcontrib><title>Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation</title><title>Pediatric blood & cancer</title><addtitle>Pediatr Blood Cancer</addtitle><issn>1545-5017</issn><issn>1545-5017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkMFu1TAQRS0EoqWw4AfQLFk0xY6dl2RZUl5BeohKRGL5NLYn1JDYwbFVwq_xcwQoEqu5Gh0dXV3Gngt-ITgvX83aXEihmvYBOxWVqoqKi_rhf_mEPVmWLxu641XzmJ3ItuZl05an7GcfCdNEPkEYAOGGrMMUnYEbTO73-86lW-hCJHjtvHX-M-zRpBDh0uRE8H6lMTgLB8pfaXKbISyp6NYUUvi-afpbijiv8OmPZk0YUTtP53CF2YeYtTPOnwN6C9c0pfwjT6hhH8Yx3JEFvcLHRBN0NI7QR_TLPKJPW7fgn7JHA44LPbu_Z6zfv-m7t8Xhw_W77vJQzNWuLJRphB5sa7VUqqkt6lKiMUJIWbVmUC3X5U4bMrImLawSph64sEI0NTdUK3nGXv7VzjF8y7Sk4-QWs_VBTyEvx235WjXb-rsNfXGPZj2RPc7RTRjX47-95S-XBoTq</recordid><startdate>20241219</startdate><enddate>20241219</enddate><creator>Sheikh, Irtiza N</creator><creator>Uwaezuoke, Destiny</creator><creator>Okeleji, Olayinka</creator><creator>Quesada, Andres</creator><creator>Herzog, Cynthia E</creator><creator>Ragoonanan, Dristhi</creator><creator>Tewari, Priti</creator><creator>Petropoulos, Demetrios</creator><creator>McCall, David</creator><creator>Nunez, Cesar</creator><creator>Roth, Michael</creator><creator>Cuglievan, Branko</creator><creator>Khazal, Sajad</creator><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6411-8353</orcidid><orcidid>https://orcid.org/0009-0005-3770-1139</orcidid><orcidid>https://orcid.org/0000-0003-4869-8818</orcidid><orcidid>https://orcid.org/0000-0003-2297-9670</orcidid></search><sort><creationdate>20241219</creationdate><title>Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation</title><author>Sheikh, Irtiza N ; Uwaezuoke, Destiny ; Okeleji, Olayinka ; Quesada, Andres ; Herzog, Cynthia E ; Ragoonanan, Dristhi ; Tewari, Priti ; Petropoulos, Demetrios ; McCall, David ; Nunez, Cesar ; Roth, Michael ; Cuglievan, Branko ; Khazal, Sajad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p562-4c81bfd9db34487dab23acc113359cf490b26bcec37eb1d41c7f01d11870ce743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheikh, Irtiza N</creatorcontrib><creatorcontrib>Uwaezuoke, Destiny</creatorcontrib><creatorcontrib>Okeleji, Olayinka</creatorcontrib><creatorcontrib>Quesada, Andres</creatorcontrib><creatorcontrib>Herzog, Cynthia E</creatorcontrib><creatorcontrib>Ragoonanan, Dristhi</creatorcontrib><creatorcontrib>Tewari, Priti</creatorcontrib><creatorcontrib>Petropoulos, Demetrios</creatorcontrib><creatorcontrib>McCall, David</creatorcontrib><creatorcontrib>Nunez, Cesar</creatorcontrib><creatorcontrib>Roth, Michael</creatorcontrib><creatorcontrib>Cuglievan, Branko</creatorcontrib><creatorcontrib>Khazal, Sajad</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric blood & cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheikh, Irtiza N</au><au>Uwaezuoke, Destiny</au><au>Okeleji, Olayinka</au><au>Quesada, Andres</au><au>Herzog, Cynthia E</au><au>Ragoonanan, Dristhi</au><au>Tewari, Priti</au><au>Petropoulos, Demetrios</au><au>McCall, David</au><au>Nunez, Cesar</au><au>Roth, Michael</au><au>Cuglievan, Branko</au><au>Khazal, Sajad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation</atitle><jtitle>Pediatric blood & cancer</jtitle><addtitle>Pediatr Blood Cancer</addtitle><date>2024-12-19</date><risdate>2024</risdate><spage>e31489</spage><pages>e31489-</pages><issn>1545-5017</issn><eissn>1545-5017</eissn><cop>United States</cop><pmid>39702892</pmid><doi>10.1002/pbc.31489</doi><orcidid>https://orcid.org/0000-0002-6411-8353</orcidid><orcidid>https://orcid.org/0009-0005-3770-1139</orcidid><orcidid>https://orcid.org/0000-0003-4869-8818</orcidid><orcidid>https://orcid.org/0000-0003-2297-9670</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1545-5017 |
ispartof | Pediatric blood & cancer, 2024-12, p.e31489 |
issn | 1545-5017 1545-5017 |
language | eng |
recordid | cdi_proquest_miscellaneous_3147484896 |
source | Wiley-Blackwell Read & Publish Collection |
title | Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A15%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20a%20Pediatric%20Patient%20with%20Core%20Binding%20Factor%20Acute%20Myeloid%20Leukemia%20Post-Cytotoxic%20Therapy%20With%20Cytarabine,%20Daunorubicin,%20and%20Gemtuzumab%20Followed%20by%20Stem%20Cell%20Transplantation&rft.jtitle=Pediatric%20blood%20&%20cancer&rft.au=Sheikh,%20Irtiza%20N&rft.date=2024-12-19&rft.spage=e31489&rft.pages=e31489-&rft.issn=1545-5017&rft.eissn=1545-5017&rft_id=info:doi/10.1002/pbc.31489&rft_dat=%3Cproquest_pubme%3E3147484896%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p562-4c81bfd9db34487dab23acc113359cf490b26bcec37eb1d41c7f01d11870ce743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3147484896&rft_id=info:pmid/39702892&rfr_iscdi=true |